Dapagliflozin Improves Heart Structure in HFpEF Patients with Type 2 Diabetes:Study Jacinthlyn Sylvia7 Aug 2025 9:30 AM ISTA new study published in the European Journal of Medical Research revealed that dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2)...
Dapagliflozin Reduces Heart Failure Risk After TAVI: Key Findings from the DapaTAVI Trial Deeksha Bhandari6 Aug 2025 8:30 AM ISTDapagliflozin significantly reduced the risk of all-cause mortality or worsening heart failure by 28% in high-risk patients undergoing transcatheter...
Dapagliflozin reduced mortality risk in aortic stenosis patients undergoing TAVI: Study Jacinthlyn Sylvia2 Aug 2025 8:45 AM ISTA new study published in The New England Journal of Medicine showed that daily dapagliflozin dramatically reduced the risk of death or deteriorating...
Uncontrolled T2D in India: Valuable Consideration for Dapagliflozin Sitagliptin Combination Dr. D.C. Sharma25 July 2025 12:11 PM ISTIndia accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India are living with diabetes,...
Eris Gets CDSCO Panel Nod To Dapagliflozin-Bisoprolol-Sacubitril Valsartan Combo Kit, Phase IV Trial Mandated Parthika Patel23 July 2025 7:41 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Cardiovascular division of the Central Drugs Standard Control Organisation (CDSCO) has...
Dapagliflozin Shines in Post-TAVI Patients:DAPA-TAVI Trial Findings Dr. Prem Aggarwal2 July 2025 11:01 AM ISTDapagliflozin reduced the risk of all-cause mortality or worsening heart failure by 28% in patients with aortic stenosis undergoing transcatheter...
State Drug Alert: CDSCO Flags 128 Batches Including Paracetamol, Dapagliflozin Farhat Nasim22 Jun 2025 3:00 PM ISTNew Delhi: As part of its ongoing quality surveillance efforts, the Central Drugs Standard Control Organisation (CDSCO) has flagged more than 120...
Medical Bulletin 20/June/2025 Dr. Bhumika Maikhuri20 Jun 2025 3:00 PM ISTHere are the top medical bulletins for the day:Digital Inhalers May Predict COPD Flare-Ups: Study FindsDigital inhalers may help predict impending...
Clinical Trial Shows Combination Therapy May Benefit Teens with Type 1 Diabetes Dr. Bhumika Maikhuri20 Jun 2025 8:30 AM ISTA clinical trial has found that combining standard insulin therapy with the investigational drug dapagliflozin can improve kidney function, blood...
Windlas Biotech Gets SEC Nod to Manufacture Dapagliflozin-Pioglitazone FDC Parthika Patel17 Jun 2025 6:20 PM ISTNew Delhi: The Subject Expert Committee (SEC) for Endocrinology & Metabolism under the Central Drugs Standard Control Organisation (CDSCO) has...
Zibotentan-Dapagliflozin Combo Shows Promising Results in CKD Patients With and Without Diabetes: Study Medha Baranwal15 Jun 2025 9:15 PM ISTDenmark: A recent post hoc analysis from the ZENITH-CKD trial suggests that combining zibotentan, a selective endothelin receptor antagonist, with...
Dapagliflozin Improves MASH Without worsening liver fibrosis in new Trial Dr. Shravani Dali12 Jun 2025 11:00 AM ISTResearchers have found in a randomized trial in China that dapagliflozin, an SGLT2 inhibitor, improved metabolic dysfunction-associated...
